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Aims: Attentional bias (AB), alcohol craving, and anxiety have important implications in 
the development and maintenance of alcohol use disorder (AUD). The current study aims 
to test the effectiveness of a Virtual Reality Cue-Exposure Therapy (VR-CET) to reduce 
levels of alcohol craving and anxiety and prompt changes in AB toward alcohol content.
Method: A 49-year-old male participated in this study, diagnosed with severe AUD, who 
also used tobacco and illicit substances on an occasional basis and who made several 
failed attempts to cease substance misuse. The protocol consisted of six VR-CET booster 
sessions and two assessment sessions (pre- and post-VR-CET) over the course of 
5 weeks. The VR-CET program consisted of booster therapy sessions based on virtual 
reality (VR) exposure to preferred alcohol-related cues and contexts. The initial and final 
assessment sessions were focused on exploring AB, alcohol craving, and anxiety using 
paper-and-pencil instruments and the eye-tracking (ET) and VR technologies at different 
time points.
Results: Pre and post assessment sessions indicated falls on the scores of all instruments 
assessing alcohol craving, anxiety, and AB.
Conclusions: This case report, part of a larger project, demonstrates the effectiveness 
of the VR-CET booster sessions in AUD. In the post-treatment measurements, a variety 
of instruments showed a change in the AB pattern and an improvement in craving and 
anxiety responses. As a result of the systematic desensitization, virtual exposure gradually 
reduced the responses to significant alcohol-related cues and contexts. The implications 
for AB, anxiety and craving are discussed.
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INTRODUCTION
Abstinence maintenance remains one of the greatest challenges 
in alcohol use disorder (AUD) treatment. Previous findings 
demonstrated that the interplay between cognitive bias of 
processing alcohol content [e.g., attentional bias, (AB)], affective 
mechanisms and implicit elicitation of alcohol craving contribute 
to the development and maintenance of AUD (Manchery 
et  al., 2017; Anker et  al., 2018). As a result of excessive 
alcohol use, AB reflects an automatic processing response 
that prioritizes alcohol-related stimuli over other environmental 
stimuli (Field et al., 2014; Wilcockson et al., 2019) and triggers 
alcohol craving, described in the literature as an intense urge 
to consume alcohol (Drummond, 2001). In addition to AB, 
alcohol craving is directly triggered by affective mechanisms 
such as stress and anxiety (McCaul et  al., 2017; Anker et  al., 
2018), particularly when alcohol cues are present (Sinha et al., 
2011) and results in a repertoire of approach or drinking 
behavioral tendencies (van Lier et  al., 2018).
There are several methods depicted in the literature that aim 
to explore alcohol cravings, such as neuro-psychophysiological 
instruments (Quintana et al., 2013; Tabakoff and Hoffman, 2013), 
self-reports (e.g., questionnaires; Kavanagh et al., 2013), cognitive 
and/or behavioral tasks (Franken, 2002; Field et al., 2008; Kavanagh 
et  al., 2013; Schlauch et  al., 2013; Lee et  al., 2014; Kim and 
Lee, 2015), some of them in combination with the cue-exposure 
paradigm. The cue-exposure paradigm generally involves in vivo, 
imagery or multimedia exposure to alcohol-related cues and 
contexts to explore different underlying mechanisms of AUD, 
including alcohol cravings (Mellentin et al., 2017a). Such method 
emerged into the cue-exposure therapy (CET) approach, which 
aims to extinguish responses to alcohol craving by following the 
principles of systematic desensitization (Mellentin et  al., 2017b). 
This therapeutic approach involves prolonged and repeated exposure 
to alcohol cues and the ultimate goal is to gradually reduce 
psychophysiological, affective, and cognitive responses to alcohol 
craving (Vollstädt-Klein et al., 2011). Although this psychological 
intervention has been employed in many studies, two meta-
analyses concluded that CET in AUD show inconsistent results 
and limited positive outcomes (Conklin and Tiffany, 2002; Mellentin 
et al., 2017a). This is mainly because the therapy sessions involved 
exposure to one alcohol cue at a time (e.g., one bottle/glass of 
alcoholic beverage), within a clinical context, which delays 
generalization of therapy effects into naturalistic settings.
Emerging technologies like virtual reality (VR) and 
eye-tracking (ET) may complement existing methods in 
terms of assessment and treatment instruments applied in 
mental health (Segawa et  al., 2020). These technologies 
provide high levels of ecological validity that approximate 
laboratory and naturalistic observations and its outcomes 
(Parsons, 2015; Segawa et  al., 2020; Simon et  al., 2020). 
For instance, VR can add effectiveness to conventional CET 
as a result of its fully enriched and immersive real-life 
simulations, which enhances the sense of presence within 
the VR environments (Hone-Blanchet et  al., 2014; Ghiţă 
and Gutiérrez-Maldonado, 2018; Segawa et  al., 2020). In 
AUD, VR has been implemented as an assessment instrument 
to elicit alcohol craving (Bordnick et al., 2008; Ryan et al., 2010; 
Kim and Lee, 2015) and as a treatment tool to reduce 
craving responses related to alcohol content (for example, 
see Hyun et  al., 2013; Son et  al., 2015). These studies 
using the VR technology have shown consistent results in 
terms of elicitation or reduction of subjective craving for 
alcohol (Ghiţă and Gutiérrez-Maldonado, 2018).
Regarding the use of the ET technology, it has been 
implemented mainly as an assessment instrument to explore 
patterns of eye-movement activity in relation to different AUD 
mechanisms like AB, drug craving, approach-avoidance 
tendencies (for instance, see Wilcockson et  al., 2019). More 
recently, ET has been studied as a cognitive training instrument 
to modify AB toward motivationally salient stimuli (Mondino 
et  al., 2020). Hence, ET parameters like first fixation, dwell 
time, or number of fixations derived from the individual’s 
oculomotor activity, are among the robust variables to detect 
AB toward alcohol content (Maurage et al., 2020). First fixation 
is the initial orientation or the very first gaze (fixation) point 
toward salient stimuli and depicts an implicit, automatic, early-
stage attention processing (Schoenmakers et al., 2008). Number 
of fixations reflects the number of times an individual made 
a fixation toward one of the stimuli (Frings et  al., 2018). 
Dwell time is understood as the total time observing a certain 
stimulus (Schoenmakers et al., 2008). Both number of fixations 
and dwell time variables reflect the maintenance stage of 
attention processing.
Considering the growing interest in digital health 
applications, the current study is part of a larger project 
entitled “ALCO-VR: Virtual Reality-based protocol for the 
treatment of patients diagnosed with severe alcohol use disorder,” 
which aims to test the effectiveness of Virtual Reality 
Cue-Exposure Therapy (VR-CET) in patients diagnosed with 
severe AUD. The first study in this project was focused on 
the identification of alcohol-related cues and contexts that 
trigger craving, in order to create clinically significant virtual 
environments (Ghiţă et  al., 2019a). The results of that study 
indicated that the most frequent alcohol-related contexts were 
a bar, a restaurant, a pub, and at-home environments. The 
patients self-reported a wide range of alcoholic beverages 
and we  included a menu of 22 alcoholic drinks in the VR 
platform. Hence, based on patients’ experiences, the second 
study of the project emphasized the development and validation 
of the “ALCO-VR” platform (Ghiţă et  al., 2019b). A third 
study carried out as part of the project aimed to develop an 
AB assessment task using the ET technology. In this study, 
a visual attention task (VAT) was created to explore gaze 
patterns toward alcohol-related images vs. neutral images 
(Ghiţă et  al., 2019c). The results of the third study, the VAT 
explored with the ET technology, were introduced in the last 
study of the project as a pre-post measurement of the efficacy 
effectiveness of VR-CET with the aim of exploring changes 
in gaze patterns. The final study in the project, a multi-site 
clinical trial, is currently implementing the outcomes of the 
previous studies to test the effectiveness of VR-CET in AUD 
patients (Hernández-Serrano et  al., 2020). The main objective 
of the trial is to explore the clinical potential of VR-based 
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therapy vs. treatment-as-usual (TAU) in AUD patients. At 
the moment of reporting this study, the clinical trial was an 
ongoing study.
The current study is a case report of a patient diagnosed 
with severe AUD, considered resistant to TAU, who took part 
in the last study of the ALCO-VR project, the clinical trial. 
The objective of the current study was to test the feasibility 
of the VR-CET protocol within the clinical trial. Once the 
patient completed the VR-CET program, our research group 
increased the sample size and are currently comparing VR-CET 
vs. TAU in AUD patients. Repeated, systematic and gradual 
exposure to VR alcohol cues and environments was performed 
as part of the psychological intervention (six VR-CET sessions). 
AB, alcohol craving, and anxiety levels were explored with 
different instruments before and after the VR-CET administration. 
Momentary levels of alcohol craving and anxiety were also 
examined during the six VR-CET sessions. Changes in AB 
patterns and reductions in alcohol craving and anxiety were 
expected at post-VR-CET assessment.
CASE DESCRIPTION
Patient A
Clinical and Personal History
Patient A was a 49-year-old divorced man, father of two 
children, with an elementary educational background and low 
socio-economic status. He  was the owner of two small bars. 
Family members with problematic use of substances included 
patient’s father (alcohol), uncle (alcohol), two brothers (alcohol, 
opioids, and stimulants), and previous partner (alcohol). The 
age of onset for alcohol consumption was 13. At the age of 
16, patient used stimulants (cocaine) and cannabis for the first 
time. The age of onset for using opioids (heroin), hallucinogens 
(Lysergic acid diethylamide, LSD), and other stimulants 
(amphetamine) was 19. From the age of 20 until the age of 
38, patient A underwent eight in/outpatient treatments for 
substance use disorders at a different hospital in Barcelona, 
Hospital Sant Pau. Treatment at this hospital included individual 
psychotherapy, group therapy, and pharmacotherapy (disulfiram, 
anxiolytics, and antipsychotic medication). Patient A maintained 
abstinence during treatments only, followed by alcohol abuse 
after treatment discharges.
Treatment at Hospital Clinic of Barcelona
At the age of 38, patient A received treatment for liver 
cirrhosis at Hospital Clinic of Barcelona, and he was derived 
then to the Addictive Behaviors Unit from the same hospital. 
Patient had a first appointment with a clinical psychologist 
but abandoned the treatment soon after. Between the age 
of 38 and 42, it is unknown whether the patient received 
treatment at a different hospital, either at public or private 
settings. At the age of 42, patient A had an overdose as a 
result of a combination of several substances: alcohol, 
stimulants, hallucinogens, and antipsychotic medication. After 
discharge from the intensive care unit for addressing the 
overdose episode, patient had a continuous pattern of alcohol use. 
At 46, patient A was administered two inpatient-based 
treatments for alcoholic hepatitis at Hospital Clinic of 
Barcelona. He  had a 9-day abstinence period between these 
treatments for alcoholic hepatitis, followed by alcohol abuse 
after the second treatment discharge. Patient was again 
directed to the Addictive Behaviors Unit at the same hospital. 
At the second appointment with the clinical psychologist, 
patient A reported several motives to cease substance misuse: 
a hazardous pattern of substance use, severe alcohol withdrawal 
syndrome, numerous failed attempts to maintain abstinence 
over a prolonged period of time, severe alcohol craving, 
alcohol tolerance [patient A was consuming 26 standard 
drink units (SDU)/day at the time of the appointment at 
the age of 46], alongside using other illicit substances and 
tobacco on an occasional basis. A SDU is a single consumption 
of 10  g of ethanol (the standard quantity of wine or beer 
and half the standard quantity of liquor; Llopis Llácer et  al., 
2000). In addition to substance misuse, patient A reported 
psycho-social and economic concerns (divorce, family 
substance abuse, and unemployment).
Psychiatric Assessment
Patient A was assessed by different professionals at the Addictive 
Behaviors Unit (clinical psychologist and psychiatrist). Patient 
A fulfilled the criteria for antisocial personality disorder. In 
addition, the outcomes of the assessments indicated severe 
alcohol use disorder, moderate tobacco use disorder, moderate 
stimulant use disorder (cocaine), mild cannabis use disorder, 
mild sedative, hypnotic, or anxiolytic use disorder (as a result 
of continuous use of benzodiazepine-based medication) 
according to the Diagnostic and Statistical Manual of Mental 
Disorders (American Psychiatric Association, 2013). As patient 
A experienced numerous relapses after treatment discharges 
and even had a continuous alcohol consumption pattern 
during outpatient-based treatment, he was considered “resistant 
to TAU.”
Treatment-as-Usual at the Addictive Behaviors Unit
Patient underwent a detoxification program on an inpatient 
basis with clonazepam. Then pharmacotherapy included 
disulfiram, anxiolytic and gabapentin medication on an outpatient 
basis (disulfiram and anxiolytic medication from 46 to 49 years 
and gabapentin for several months at the age of 49). The 
psychological treatment followed a multidisciplinary protocol, 
including cognitive-behavioral, motivational, and third-wave 
therapeutic approaches at an individual and group level. Urine 
analyses were collected tri-weekly. From the age of 46 until 
49, while under TAU at the Addictive Behaviors Unit, patient 
A was admitted to several therapeutic communities in Barcelona 
but abandoned after a maximum of 3–4  weeks. Despite the 
efforts from a multidisciplinary approach, patient A had a 
maximum of 4  weeks of abstinence each time there was an 
attempt to cease substance use, from 46 until the age of 49 
as self-reported the patient and confirmed by urine analyses. 
He  experienced several relapses mainly with alcohol, and 
occasionally with cocaine and cannabis. Overall, patient A 
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had a continuous and hazardous pattern of alcohol consumption 
and occasional use of illicit substances from the age of 16 
until 49.
VR-CET Program
At the age of 49, patient A was introduced to the VR-CET 
program as part of a larger clinical trial [the ethical code 
number of the clinical trial is 0377 (HCB/2017/0377) and the 
approval date was 09/2017]. Until that moment, patient A had 
never experienced a VR-based psychological treatment. At the 
moment of his inclusion in the study, patient A was under 
outpatient treatment at the Addictive Behaviors Unit, receiving 
medication and psychological treatment as detailed in the TAU 
at the Addictive Behaviors Unit. A month before the first 
appointment with the clinician-scientist from the University 
of Barcelona, patient A used alcohol, tobacco, cannabis, and 
cocaine. The entire VR-CET protocol lasted for 5  weeks, with 
two assessment sessions (pre-and post-VR-CET and six VR-CET 
booster sessions). Then, patient A abandoned the treatment 
received at the Addictive Behaviors Unit. Figure  1 represents 
a visual overview (VA) of the patient’s relevant current and 
past clinical data.
Given the complexity of patient A’s psychological status and 
medical concerns, in addition to the fact that he  had an 
unfavorable response to previous therapies, we  aimed at 
contributing to the educational, scientific, and clinical practice 
communities by illustrating a novel therapeutic approach and 
highlighting the clinical potential of technologies like virtual 
reality and eye-tracking in addressing the underlying 
mechanisms of AUD.
Assessment Measures
Paper-and-Pencil Instruments (Pre-Post VR-CET 
Assessment)
Alcohol misuse patterns were assessed with the Alcohol Use 
Disorder Identification Test (AUDIT; Saunders et  al., 1993). 
The Spanish version of AUDIT (Contel Guillamón et al., 1999) 
is a 10-item scale, and responses to each item were scored 
from 0 to 4, with a maximum score of 40. A total score 
equal to or higher than eight points indicates a hazardous 
drinking pattern and a score higher than 15 is likely to 
indicate alcohol dependence (Saunders et  al., 1993; Higgins-
Biddle and Babor, 2018; Nadkarni et  al., 2019). Test-retest 
reliability and internal consistency regarding the original and 
language-adapted versions of AUDIT present satisfactory 
properties (de Meneses-Gaya et  al., 2009).
Craving was explored with the Multidimensional Alcohol 
Craving Scale (MACS; Guardia Serecigni et  al., 2004). The 
MACS is a Spanish scale assessing the intensity of alcohol 
craving experienced by the individual throughout the previous 
week. The scale presents robust validity and reliability 
properties (Guardia Serecigni et  al., 2004). Each item scores 
ranged from 1 (“Strongly disagree”) to 5 (“Strongly agree”). 
The MACS has three outcome scores: “desire to drink,” 
“behavioral disinhibition,” and the total score. Based on 
responses to the MACS items, these scores were classified 
as non-existent, mild, moderate, or intense alcohol craving. 
In addition, an ad-hoc modified version of MACS (MACS-
VR) was introduced in the protocol to assess alcohol craving 
after VR exposure. The questionnaire items remained the 
same as in the original MACS, although the instructions 
were no longer to assess the “intensity of alcohol craving 
experienced throughout the previous week,” but to assess 
the “intensity of alcohol craving experienced during 
VR exposure.”
Anxiety was assessed by the Spanish version of the State-
Trait Anxiety Inventory (STAI; Spielberger et  al., 1971). The 
STAI is a self-reported questionnaire with two subscales 
assessing state anxiety and trait anxiety. Each subscale 
consisted of 20 items, and scores on each item ranged from 
0 (“Not at all”) to 3 (“Very much so”). The Spanish version 
of STAI has robust validity and good internal consistency 
properties (Spielberger et  al., 1971).
Attentional bias was explored with two instruments: the 
Spanish version of the Alcohol Stroop Test (Sánchez-López 
et  al., 2015) and a VAT. The Alcohol Stroop Test is an adapted 
version of the classic Stroop task used to assess the interference 
caused by alcohol stimuli in individuals with problematic alcohol 
use and AUD. The Alcohol Stroop Test presents good test-
retest reliability and good convergent, discriminant and predictive 
validity (Hallgren and McCrady, 2013).
Eye-Movement Activity Data (Pre-Post VR-CET 
Assessment)
The VAT aimed to explore AB using the ET technology. The 
VAT stimuli consisted of alcohol-related images vs. neutral 
images. Alcohol-related images were selected based on the 
results of the Spanish National Health Survey on Alcohol 
Consumption (2011/2012). The outcomes of this survey indicated 
that the most frequently consumed alcoholic beverages were 
beer, followed by wine and liquors. Neutral images were 
colorful office-related objects (pencils, sticky notes, writing 
boards, etc.), as seen in previous research (Castellanos et  al., 
2009; Donohue et  al., 2016). Each image was presented at 
960 × 960 pixels. The angle of observation between the patient 
and the VAT presented on the monitor was 90  cm. The VAT 
comprised 144 stimuli (12 images related to alcohol  ×  12 
neutral images) and was presented to the patient as a false 
visual memory task. This false task consisted of 18 trials 
(eight pairs of images per trial) in which the patient reported 
whether he  had seen a certain image or not in the previously 
seen trial. All pairs of images were counterbalanced and each 
pair of images appeared on the screen for 3  s. After each 
pair of images, a gray background appeared for 1  s with a 
fixation point in the center of the screen aiming to return 
to a focal point.
Momentary Levels of Craving and Anxiety
Momentary levels of alcohol craving and anxiety were assessed 
with Visual Analog Scales (VAS). These scales are frequently 
used as self-reported scales (Bordnick et  al., 2008) to indicate 
craving (VAS-C) and anxiety (VAS-A) during VR exposure. 
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The VAS-C is a self-reported subjective craving scale, with 
scores ranging from 0 (no craving) to 100 (intense craving). 
Similarly, the VAS-A is a self-reported scale which explores 
anxiety levels, with scores ranging from 0 (no anxiety) to 100 
(intense anxiety).
Urine Analyses
Urine samples were collected tri-weekly during TAU at the 
Addictive Behaviors Unit from Hospital Clinic of Barcelona, 




The ET equipment consisted of the Gazepoint GP3 HD eye tracker 
(150  Hz system, 0.5–1.0 degree of visual angle accuracy, 35  cm 
(horizontal)  ×  22  cm (vertical) movement, and ±15-cm range of 
depth movement) to record eye movement activity, a laptop to 
register the data, a 19'' monitor to display the VAT at a resolution 
of 1,280  ×  1,024, and a chin-rest to avoid head movements.
The VR equipment consisted of an Oculus Rift S head-mounted 
display (HMD), sensors, touch controllers, and a computer 
compatible with VR technology (INTEL® Core™ i7–2,600 CPU, 
FIGURE 1 | A timeline of patient’s relevant current and past clinical data.
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16.0  GB RAM, 64-bit operating system, x64 processor, and a 
NVIDIA GeForce GTX 1080 Ti graphic card).
Software
The “ALCO-VR” software was created based on the results of 
a previous study (Ghiţă et  al., 2019a) in which we  identified 
alcohol-related triggering stimuli and contexts for craving 
elicitation in a sample of patients diagnosed with AUD. The 
software consists of a neutral environment (a room with white 
background and a glass of water), where users could familiarize 
themselves with the VR technology, and four alcohol-related 
environments: restaurant, bar, pub, and at home environments 
(Figure  2). These scenarios were created considering different 
variables as in previous research, such as social interactions 
(including avatars in the environments), different alcohol-related 
cues (a menu of 22 alcoholic drinks), or different times of 
day (day time or night time). “ALCO-VR” consists of two 
parts, assessment and therapy. In the assessment part, users 
choose their first five preferred alcoholic beverages from the 
menu of drinks. The software itself was set to create a hierarchy 
of exposure from the lowest rated environment (context) with 
the lowest rated alcoholic drink (alcohol-related cue, from the 
first five preferred drinks) to the highest rated environment 
and drink. Every 20  s, the user was asked to self-report their 
alcohol craving and anxiety levels on VASs. The therapy part 
of “ALCO-VR” was based on the previous assessment part, 
and involved exposure to significant alcohol-related cues and 
contexts, as initially selected by the patient. Unlike the assessment 
part, the therapy system implied self-reports on VASs every 
60  s. Only if the ratings were 40% less than the initial ratings 
on both VAS-C and VAS-A was the user allowed to continue 
to the next level. The platform permitted a high level of 
interaction with the VR environments, where individuals 
approach their alcoholic beverages, grab and observe them 
from all angles with Oculus Touch controllers.
Procedure of the VR-CET Program
Patient A was recruited from the Addictive Behaviors Unit, Hospital 
Clinic of Barcelona and after providing his written informed 
consent, he  was assigned to the VR-CET group. The initial 
assessment session consisted of collecting personal data such as 
AUD history, medication, and abstinence data. The patient was 
asked to complete the AUDIT (Total score  =  28), MACS and 
STAI (only the trait part), and the Alcohol Stroop Task. Then, 
AB was assessed with the VAT using the ET technology. Following 
the VAT, the VR assessment task from the “ALCO-VR” software 
was administered. A hierarchy based on his preferences was created 
by the “ALCO-VR” software, and the Oculus Rift HMD was 
attached to his head. After a short tutorial to familiarize him 
with the VR technology and the controllers, the patient was asked 
to rate his momentary levels of anxiety and craving when exposed 
to the alcoholic drinks (every 20  s) within the VR environments 
on the VAS-A and VAS-C. After the assessment task, the patient 
was administered the MACS-VR and the state part of the STAI. 
Following this initial assessment session, the patient was administered 
VR-CET sessions twice a week for 3  weeks. Each therapy session 
lasted approximately 1  h, with 50  min of exposure therapy and 
generally 10–20  min of psychological debriefing. The sessions 
consisted of a gradual exposure to the same preferred stimuli 
and environments as elected in the assessment part, starting with 
the lowest rated environment and lowest rated alcoholic beverage. 
During the therapy sessions, the patient was exposed for at least 
60  s to each of the preferred alcoholic drinks in each one of 
the four environments. Hence, every 60 s, the patient self-reported 
FIGURE 2 | Images of the virtual reality (VR) alcohol-related environments.
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his momentary alcohol craving and anxiety levels on VAS-C 
(50 ratings) and VAS-A (50 ratings). Three days after completion 
of the six VR-CET booster sessions, the post-treatment session 
(the final assessment) consisted of a similar protocol as the initial 
assessment session. Regardless of the nature of the session (either 
assessment or therapy), the patient received a short debriefing at 
the end of each session in order to reduce cravings and to 
minimize further possible consumption. The assessment and 
treatment sessions were delivered by an experienced clinician-
scientist at VR-Psy Lab, University of Barcelona. With the aim 
to decrease momentary levels of anxiety and craving and to further 
minimize the possibility of a relapse, the therapist conducted a 
brief psychological debriefing at the end of each VR-CET booster 
sessions (between 10 and maximum 20  min). The debriefing 
consisted of asking the patient to narrate the situation he  was 
experiencing, including his thoughts, emotions, and behavioral 
schemas. In addition, each debriefing included deep diaphragmatic 
breathing for several minutes as suggested by previous research 
(Priddy et  al., 2018). Addressing these concerns, the patient was 
allowed to leave the laboratory setting only when his responses 
were classified as “non-pathological” by the therapist. Only when 
the patient reported momentary levels of alcohol craving and 
anxiety less than 25 (out of 100), the session was concluded. 
Figure  3 details pre-post booster sessions and intra-session 
assessment of the VR-CET program.
Data Analysis
Paper-and-Pencil Instruments (Pre-Post VR-CET)
A similar approach to the ET data was applied to Alcohol 
Stroop Task and STAI. A positive outcome would be represented 
by lower scores in attention bias and state and trait anxiety 
at post-VR-CET assessment session, whereas a negative 
outcome would be indicated by the opposite patterns (Julian, 
2011; Sánchez-López et  al., 2015). To determine significant 
changes regarding alcohol craving as assessed by the MACS 
and MACS-VR, the total scores were interpreted as: 
“non-existent” craving [(≤12) which is also the cut-off 
score], “mild” (13–22), “moderate” (23–40), and “intense” 
(>40; Guardia Serecigni et  al., 2004).
The Eye-Movement Activity Data (Pre-Post 
VR-CET Assessment)
The Open Gaze and Mouse Analyzer (Ogama) software was 
used to design areas-of interest (AOI) within each VAT image 
(AOI-alcohol for images with alcohol content, AOI-neutral for 
images with neutral content), and extract the raw eye-movement 
data. Within each AOI (AOI-neutral and AOI-alcohol), 
we computed three dependent variables: dwell time, the number 
of fixations, and first fixation. These data were transferred to 
Excel and an additional data transformation was carried out 
(e.g., computing percentage of each ET variable). McNemar 
tests were performed for each one of the variables between 
pre- and post-VR-CET. Regarding the ET data, a positive 
outcome would mean that the patient displayed the same 
interest in observing neutral images and alcohol-related images 
at post-VR-CET assessment. A negative outcome would 
be indicated by displaying more attention to the alcohol-related 
images, as well as by displaying more attention to the neutral 
images (as this last gaze pattern could be  the result of an 
avoidance behavior).
FIGURE 3 | Pre-post Virtual Reality Cue-Exposure Therapy (VR-CET) and intra-session assessment.
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Momentary Levels of Craving and Anxiety
Regarding scores of momentary levels of alcohol craving and 
anxiety, previous research indicated that VASs are a reliable 
measure to indicate clinically significant changes in cue-induced 
drug cravings (Ekhtiari et  al., 2010; Yeung and Wong, 2019) 
and anxiety (Williams et  al., 2010), with scores between 0 
and 25 (“not at all” craving/anxiety), 25–50 (“mild” craving/
anxiety), 50–75 (“moderate” craving/anxiety), and >75 
(“extreme or intense” craving/anxiety; Reid et  al., 1998; 
Williams et  al., 2010; Lundahl and Johanson, 2011). The 
cut-off score was set at <25 for both VAS-C and VAS-A in 
our study. At pre- and post-VR-CET assessment, we determined 
the means and SD of VAS-A and VAS-C in Excel corresponding 
to the assessment part of the “ALCO-VR” software. Regarding 
the intra-therapy VASs from the therapy part of the “ALCO-
VR” software, we  emphasized the highest and final values 
as clinically significant scores to examine cue-induced craving 
and anxiety (Pla-Sanjuanelo et al., 2016). In addition, Reliable 
Change Indexes (RCIs) were computed for MACS, MACS-VR, 
STAI (state and trait), VAS-A, VAS-C, Alcohol Stroop Task 
to explore significant changes at post-assessment session 
following the guidelines of Jacobson and Truax (1991). We also 
added z-scores of the questionnaires: normative data used 
stemmed from the overall initial clinical sample of 95 subjects 
from our project (Crawford and Howell, 1998). These scores 
are detailed in the Results section.
OUTCOMES OF THE VR-CET 
APPROACH
Pre-Post VR-CET Assessments
Table 1 shows the differences in scores as assessed by MACS, 
MACS-VR, STAI, VAS-A, and VAS-C, and the Alcohol Stroop 
Task during the first and final assessment sessions. Direct 
and z-scores from the questionnaires are emphasized in 
Table  1, alongside the results from the RCIs. Concerning 
the z-scores, the values obtained show scarce deviations from 
the mean across the different variables. As for the RCIs, 
solely the RCIs for both VAS-A and VAS-C variables were 
statistically significant, therefore expounding that the change 
was reliable beyond the change expected due to the measurement 
error alone.
The Eye-Movement Activity Data
Table  2 shows changes in the oculomotor activity patterns at 
the two moments of assessment, before and after the VR-CET 
booster sessions regarding dwell time, first gaze, and number 
of fixations. Despite not reaching statistical significance (Table 3), 
the data indicated that patient A observed more images with 
neutral content than images with alcohol-related content at 
post-VR-CET assessment session as inferred by the three ET 
variables. The first gaze variable did not follow the same pattern 
as dwell time and fixations variables. Patient A displayed an 
implicit, automatic, early-stage attention processing toward the 
alcohol-related images vs. control images at both pre- and 
post-VR-CET time points. There was a slight reduction in 
first fixation toward alcohol-related images at post-VR-CET 
assessment session. Overall, the patient tended to pay less 
attention to the alcohol-related images and observing more 
neutral images at post-VR-CET.
Momentary Levels of Craving and Anxiety 
During VR-CET Sessions
Figure  4 shows the difference between the highest value and 
the final value of cue-induced anxiety and alcohol craving in 
each session and across the six VR-CET sessions. As seen in 
previous research (Pla-Sanjuanelo et  al., 2016), the highest and 
final values are clinically significant scores to examine momentary 
levels of craving and anxiety as reported on VAS-C and VAS-A, 
respectively. During the first session, patient A reported maximum 
scores of anxiety and alcohol craving on VAS-A and VAS-C 
(100) at the 10th minute of VR-CET and were maintained 
throughout the entire therapy session. Following this first 
TABLE 3 | McNemar tests for the eye-movement activity data.
McNemar test p Chi-square 
statistic
OR (95% CI)
Dwell time 0.361 0.833 0.667 (0.293–1.463)
First gaze 0.889 0.019 0.926 (0.515–1.657)
Fixations 0.479 0.500 0.786 (0.428–1.424)















MACS 31 −0.08 12 −0.56 1.57
MACS-VR 48 +0.31 14 −0.02 1.87
STAI-trait 17 +0.89 7 +0.23 1.87













70 +0.12 66 +0.19 1.01
Reliable Change Index (RCI) is significant whenever is significant whenever *RCI > 1.96.
TABLE 2 | Eye-movement data recorded at pre-post VR-CET time points.
Eye-tracking 
data (%)











Dwell time 46 54 40 60
First gaze 54 46 52 48
Fixations 48 52 42 58
Eye-movement variables: dwell time, first gaze, and number of fixations.
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VR-CET session, momentary alcohol craving and anxiety levels 
were gradually reduced. By the end of the therapy sessions, 
the patient presented lower scores in both highest and final 
values of craving and anxiety levels. Alcohol craving levels 
decreased by 100%, whereas anxiety levels were reduced by 
95% at the end of the sixth VR-CET session compared to the 
first therapy session.
Urine Analyses
In addition, the results of tri-weekly urine analyses were negative 
and confirmed the patient’s self-reports regarding alcohol and 
illicit substance use, indicating that he  remained abstinent 
throughout his participation in the study, although tobacco 
was consumed on an occasional basis.
DISCUSSION AND CONCLUSION
Our results indicate that VR-CET booster sessions reduced 
patient’s AUD symptoms, anxiety and craving, and produced 
a change in gaze patterns. The self-report in the initial 
assessment session indicated a severe AUD problem according 
to the AUDIT (Saunders et  al., 1993), suggesting that the 
patient was experiencing a hazardous pattern of alcohol 
misuse (Donovan et al., 2006). The MACS total score indicated 
a “moderate alcohol craving” throughout daily life activities, 
particularly in the previous week before the assessment 
(Guardia Serecigni et  al., 2004). The total MACS-VR score 
was translated into an “intense craving for alcohol” 
immediately after the assessment part of the “ALCO-VR” 
software, as a result of cue-induced alcohol craving (Ghiţă 
et  al., 2019b). These scores were consistent with the 
self-reported subjective craving on the VAS-C during the 
VR assessment task. These indicators suggested to us that 
the patient was experiencing constant alcohol craving, an 
intense desire to consume, particularly in the presence of 
alcohol-related stimuli, which may further precipitate a 
relapse (Pina and Williams, 2016). Interestingly, after the 
VR-CET booster sessions, patient A self-reported notable 
reductions on all scores of instruments assessing alcohol 
craving. Post VR-CET assessment MACS scores indicated 
“non-existent alcohol craving” in the past week, and the 
MACS-VR total score reflected “mild alcohol craving” after 
VR exposure to alcohol-related content. Furthermore, the 
post-treatment VR assessment task indicated a significant 
change, almost total absence of alcohol craving as reported 
on the VAS-C, when the patient was exposed to alcohol-
related cues and contexts. In view of these results, we consider 
that our study depicts the principles of systematic 
desensitization, in which an individual undergoes a habituation 
process over repetitive and prolonged exposure to highly 
salient stimuli (Hernández-Serrano et al., 2020). We highlight 
the reduction in self-reported subjective craving for alcohol 
to be  important achievements of the VR-CET program. Our 
findings are consistent with previous research using Positron 
Emission Tomography/Computerized Tomography, which 
have shown reductions in craving for alcohol in patients 
diagnosed with AUD after participation in a 10-session VR 
therapy protocol (Son et  al., 2015).
A similar pattern was found for self-reported anxiety. Although 
patient A did not indicate a clinically significant score in 
anxiety (<40), STAI determines the momentary (state) and 
chronic (trait) anxiety levels and the initial assessment session 
indicated a higher level of state-anxiety compared to 
FIGURE 4 | Highest and final craving and anxiety values across the VR-CET sessions.
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trait-anxiety in patient A (Julian, 2011; Leal et  al., 2017). The 
higher score for state-anxiety was also determined by exposure 
to alcohol-related VR environments as depicted by previous 
research (Ghiţă et al., 2019b). These scores were highly consistent 
with the self-reported subjective anxiety on the VAS-A during 
the VR assessment task, which was significantly lower when 
the patient was exposed to alcohol-related cues and contexts. 
After the VR-CET sessions, patient A obtained notably lower 
scores on both parts of the STAI, and we  emphasize the 
reduction in state-anxiety (from 21 pre-treatment to four post-
treatment). The state-anxiety score fell considerably after the 
VR-CET sessions compared to the trait-anxiety score, particularly 
because state-anxiety is a self-regulatory process related to 
alcohol cue-induced momentary anxiety, whereas trait-anxiety 
is a more stable personality trait that indicates generalized 
anxiety levels (Leal et  al., 2017).
In terms of AB toward alcohol stimuli, patient A displayed 
an interference effect on Alcohol Stroop Task for alcohol words, 
translated as an attention bias for alcohol content. According 
to the results of Alcohol Stroop Task in the pre-post assessment 
sessions, we  interpret the lower score on the task after the 
six booster sessions as indicating decreased interference toward 
alcohol content (Hallgren and McCrady, 2013). Regarding the 
eye-movement activity, the changes in gaze patterns displayed 
by patient A after the treatment are interesting. The dwell 
time and fixation variables indicated a maintenance-stage of 
attention processing for images with neutral content, translated 
as a tendency to avoid alcohol-related images at both pre- and 
post-treatment assessment sessions. Townshend and Duka 
(2007) explained this avoidance pattern as an increased 
momentary perception of loss of inhibitory control over alcohol 
consumption. Patient A showed an increasingly active and 
conscious avoidance pattern of alcohol-related images and 
heightened approach eye-movement activity for the neutral 
content after the VR-CET booster sessions. However, the first 
fixation variable indicated the opposite gaze pattern. The first 
gaze variable is an involuntary cognitive mechanism suggesting 
automatic processing schemas (Schoenmakers et  al., 2010). 
Thus, patient A showed an implicit attention processing translated 
as an approach tendency toward alcohol-related images vs. 
neutral images in both pre- and post-treatment sessions. 
However, after the VR-CET booster sessions, the first gaze 
variable indicated a slight decreased tendency to regard alcohol-
related images and an increased tendency to observe the neutral 
images. Our findings are consistent with a previous study 
using the alcohol-visual-dot-probe-task, which showed that 
after an initial orientation toward alcohol stimuli, AUD patients 
displayed an avoidance pattern, disengaging from alcohol-related 
stimuli in the first stages of abstinence (Vollstädt-Klein et  al., 
2009). This approach-avoidance gaze pattern displayed by 
patient A has been demonstrated in other studies with individuals 
with binge eating disorder (Deluchi et  al., 2017) or gambling 
disorder (Ciccarelli et  al., 2016).
In terms of intra-session cue-induced momentary craving 
and anxiety responses, patient A initiated the VR-CET sessions 
with maximum cue-induced craving and anxiety scores, suggesting 
a high vulnerability toward alcohol-related cues and contexts, 
which may increase relapse susceptibility (Fatseas et  al., 2018). 
However, craving and anxiety responses gradually decreased over 
the course of the six VR-CET sessions, indicating a process of 
desensitization toward alcohol-related content (Hernández-Serrano 
et  al., 2020). We  depicted a slight increase in momentary levels 
of anxiety and alcohol craving in the fifth VR-CET session 
compared to the fourth session. Although it was a minor increase, 
the therapy session coincided with a previous family conflict 
the patient experienced. According to the patient, this conflict 
facilitated a “generalized feeling of distress.” Nevertheless, higher 
and final values of momentary cue-induced anxiety and craving 
had fallen by the last therapy session, almost reaching extinction 
of alcohol craving and anxiety responses.
These indicators were consistent with patient A’s daily life 
experiences, since he  reported greater self-efficacy in terms 
of managing his alcohol cravings and alcohol-related anxiety. 
This is a fundamental achievement for VR-CET sessions, as 
the main goal was to generalize this intervention’s effects to 
the real-life context of the patient. Considering patient’s 
perspective, he was highly motivated to participate in a study 
using VR-based therapy. After the intervention, the patient 
described the sessions as “engaging” and “beneficial” in helping 
him to cope with real situations associated with alcohol 
consumption. In addition, the patient highlighted the realism 
of the VR alcoholic beverages, environments, and avatars as 
positive aspects of the VR-CET booster sessions. In addition 
to self-reports using different instruments and technologies, 
the results of urine analyses confirmed no alcohol or illicit 
substance use during the VR-CET program and shortly after 
its completion, only occasional tobacco use. Although the 
VR-CET program was designed particularly to address 
AUD-related concerns, we  emphasize the clinical potential 
of the VR-CET program regarding its outcomes in terms of 
abstinence maintenance.
The outcomes of this case report should be  viewed in the 
light of study limitations. First, the current study reflects a 
single subject and therefore, solid conclusions about the short- 
and long-term effectiveness of the VR-CET will be  determined 
by the outcomes of the clinical trial and follow-ups. Second, 
the patient was under outpatient treatment at the Addictive 
Behaviors Unit from Hospital Clinic of Barcelona, receiving 
pharmacotherapy and psychological treatment during his inclusion 
in the VR-CET program. Nevertheless, we emphasize that patient 
A underwent several treatments at different hospitals including 
both psychological and pharmacological treatments, but 
he experienced relapses after treatment discharges, with maximum 
of 4  weeks of abstinence each time he  attempted to cease 
substance use. We  consider that adding the VR-CET protocol 
may enhance the baseline treatment received at the Addictive 
Behaviors Unit and may increase the abstinence period of a 
resistant to TAU patient. Third, we  did not assess other areas 
of functioning in patient A, as we  focused mainly on exploring 
AB, alcohol craving, and anxiety. For instance, examining patient’s 
emotional and personality traits would had given a more 
comprehensive overview of overall patient’s functioning.
Despite promising results, continued research is needed to 
clearly determine the effectiveness of VR applications in AUD. 
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For instance, randomized clinical trials following the “Consolidated 
Standards of Reporting Trials” (CONSORT) guidelines are 
fundamental to establish a rigorous scientific consensus regarding 
the clinical potential of VR use in AUD. Variables like social 
interaction implemented in VR environments also raise questions, 
and it should be addressed to further standardize VR applicability 
(Ghiţă and Gutiérrez-Maldonado, 2018). In addition, future studies 
may examine the effectiveness of VR-CET approach alone and 
in combination with other psychological interventions (e.g., coping 
skills training, and mindfulness). A recent systematic review 
highlighted potential limitations of VR use in AUD like cost-
effectiveness, training of professionals delivering VR-based programs, 
or patient’s compliance with the VR program (Segawa et al., 2020). 
Nevertheless, VR applications in AUD currently follow the promising 
scientific course of previously validated VR procedures in anxiety 
disorders (Maples-Keller et  al., 2017) or post-traumatic stress 
disorder (Kothgassner et  al., 2019).
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